Mumbai, February 24, 2018: Pharma Noteworthy, Biocon said that USFDA has finished a pre-endorsement investigation of its assembling office in Malaysia and issued a Frame 483 with 6 perceptions According to the typical desires of the organization, we plan to react with a remedial and preventive activity design in an auspicious way.’ -Biocon said in a recording with BSE.
UNI
· The Telerobotic-assisted Internal Mammary Artery Harvesting procedure was successfully completed in 58 minutes, with exceptional precision and…
This expansion enables DFE Pharma to offer specialized analytical services for Dry Powder Inhalation (DPI)…
Dr. Sujatha Thyagarajan, Lead & HOD - Pediatric Intensive Care and Pediatric Emergency at Aster…
Bangalore, January 13, 2025: Fortis Hospital Bannerghatta Road, has successfully treated a 53-year-old software engineer from…
Mumbai, January 13, 2025: In a landmark medical feat, a multidisciplinary team led by Dr.…
Mumbai, January 13, 2025: From the last six months, 21-year-old Pari Tulaskar [name changed) from…